Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:45 PM EST
50.24UNCH (UNCH)
Volume
789,315
Close
50.24quote price arrow up+0.53 (+1.07%)
Volume
15,109,339
52 week range
41.44 - 61.71
Loading...
  • Open49.75
  • Day High51.15
  • Day Low49.75
  • Prev Close49.71
  • 52 Week High61.71
  • 52 Week High Date12/20/21
  • 52 Week Low41.44
  • 52 Week Low Date10/11/22

Key Stats

  • Market Cap282.013B
  • Shares Out5.61B
  • 10 Day Average Volume18.75M
  • Dividend1.60
  • Dividend Yield3.18%
  • Beta0.69
  • YTD % Change-14.92

KEY STATS

  • Open49.75
  • Day High51.15
  • Day Low49.75
  • Prev Close49.71
  • 52 Week High61.71
  • 52 Week High Date12/20/21
  • 52 Week Low41.44
  • 52 Week Low Date10/11/22
  • Market Cap282.013B
  • Shares Out5.61B
  • 10 Day Average Volume18.75M
  • Dividend1.60
  • Dividend Yield3.18%
  • Beta0.69
  • YTD % Change-14.92

RATIOS/PROFITABILITY

  • EPS (TTM)5.27
  • P/E (TTM)9.53
  • Fwd P/E (NTM)10.06
  • EBITDA (TTM)42.501B
  • ROE (TTM)35.91%
  • Revenue (TTM)99.676B
  • Gross Margin (TTM)65.51%
  • Net Margin (TTM)30.35%
  • Debt To Equity (MRQ)39.59%

EVENTS

  • Earnings Date02/06/2023(est)
  • Ex Div Date11/03/2022
  • Div Amount0.40
  • Split Date-
  • Split Factor-

Related Video

Final Trades: PFE, FLEX, SMH & FL
VIDEO1:1801:18
Final Trades: PFE, FLEX, SMH & FL

Profile

MORE
Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global...
Albert Bourla Ph.D.
Chairman of the Board, Chief Executive Officer
David Denton
Executive Vice President, Chief Financial Officer
Aamir Malik
Executive Vice President, Chief Business Innovation Officer
Lidia Fonseca Ph.D.
Executive Vice President, Chief Digital and Technology Officer
Douglas Lankler
Executive Vice President, General Counsel
Address
235 E 42ND ST
New York, NY
10017-5703
United States

Top Peers

SYMBOLLASTCHG%CHG
MRK
Merck & Co Inc
110.09+1.16+1.06%
ABBV
Abbvie Inc
165.40+1.68+1.03%
RHHBY
Roche Holding AG
39.95-0.32-0.79%
JNJ